Numerous well known peptides can now not be compounded by pharmacies for human use on account of the latest FDA regulatory modifications. The FDA has moved quite a few of such substances to Category two of its Bulk Drug Substances list, citing security pitfalls or insufficient facts, earning them ineligible for compounding.Reply to  Jzhev I'm look